Pharmacokinetics of Lanraplenib in Adults With Impaired Renal Function
Clinical trial NCT02959138 · COMPLETED
Trial details
- NCT number
- NCT02959138
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-21
- Primary completion
- 2018-10-05
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.